参考文献/References:
[1] Bohan A,Peter JB. Polymyositis and dermatomyositis(second of two parts)[J].N Engl J Med,1975,292(8):403-407.
[2] 中华医学会风湿病学分会.多发性肌炎和皮肌炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(12):828-831.
[3] 侯明慧,刘升云.临床无肌病性皮肌炎与皮肌炎临床差异的探究[J].中国皮肤性病学杂志,2019,33(8):895-898.
[4] 赵琳,张晓莉.皮肌炎伴人类巨细胞病毒IgM阳性的临床分析[J].中华临床医师杂志,2016,10(13):1908-1911.
[5] Zheng Q,Zhu K,Gao CN,et al.Prevalence of Epstein-Barr virus infection and characteristics of lymphocyte subsets in newly onset juvenile dermatomyositis[J].World J Pediatr,2019[Online ahead of Print].
[6] Sato S,Hirakata M,Kuwana M,et al.Autoantibodies to a 140-kd polypeptide,CADM-140,in Japanese patients with clinically amyopathic dermatomyositis[J].Arthritis Rheum,2005,52(5):1571-1576.
[7] Sato S,Hoshino K,Satoh T,et al.RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis:Association with rapidly progressive interstitial lung disease[J].Arthritis Rheum,2009,60(7):2193-2200.
[8] Morisset J,Johnson C,Rich E,et al.Management of myositis-related interstitial lung disease[J].Chest,2016,150(5):1118-1128.
[9] Li L,Wang Q,Yang F,et al.Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis[J].Oncotarget,2017,8(16):26552-26564.
[10] Huang K,Vinik O,Shojania K,et al.Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5(MDA5)-positive dermatomyositis:a case-based review[J].Rheumatol Int,2019,39(11):1971-1981.
[11] Li L,Wang H,Wang Q,et al.Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease[J].J Neurol Sci,2019,397:123-128.
[12] Huang W,Ren F,Wang Q,et al.Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies[J].Clin Exp Rheumatol,2019,37(5):803-807.
[13] Kurasawa K,Arai S,Namiki Y,et al.Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis[J].Rheumatology(Oxford),2018,57(12):2114-2119.
[14] Motegi SI,Sekiguchi A,Toki S,et al.Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease[J].Eur J Dermatol,2019,29(5):511-517.
[15] Tokunaga K,Hagino N. Dermatomyositis with rapidly progressive interstitial lung disease treated with rituximab:a report of 3 cases in Japan [J].Intern Med,2017,56(11):1399-1403.
[16] Ning Y,Yang G,Sun Y,et al.Efficiency of therapeutic plasma-exchange in acute interstitial lung disease,associated with polymyositis/dermatomyositis resistant to glucocorticoids and immunosuppressive drugs:a retrospective study[J].Front Med(Lausanne),2019,6:239.
[17] Koguchi-Yoshioka H,Okiyama N,Iwamoto K,et al.Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules[J].Br J Dermatol,2017,177(5):1442-1446.
[18] Oryoji K,Himeji D,Nagafuji K,et al.Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis[J].Clin Rheumatol,2005,24(6):637-640.
[19] Chen Z,Cao M,Plana MN,et al.Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease:a review of the literature and a meta-analysis [J].Arthritis Care Res(Hoboken),2013,65(8):1316-1324.
相似文献/References:
[1]沈小雁,李可嘉,曹华,等.皮肌炎并发结外NK/T细胞淋巴瘤1例[J].中国皮肤性病学杂志,2013,(08):815.
SHEN Xiao-yan,LI Ke-jia,CAO Hua,et al.A Case of Extranodal NK/T Cell Lymphoma with Dermatomyositis[J].The Chinese Journal of Dermatovenereology,2013,(01):815.
[2]余先华,李季,佘小光,等.皮肌炎合并Vogt-小柳综合征1例[J].中国皮肤性病学杂志,2014,(03):294.
YU Xian-hua,LI Ji,SHE Xiao-guang,et al.A Case of Dermatomyositis with Vogt-Koyanagi Syndrome[J].The Chinese Journal of Dermatovenereology,2014,(01):294.
[3]唐鲜艳,冯媛,彭悦,等.幼年皮肌炎20例临床特点及转归分析[J].中国皮肤性病学杂志,2019,(10):1153.[doi:10.13735/j.cjdv.1001-7089.201809121]
TANG Xianyan,FENG Yuan,PENG Yue,et al.Analysis of Clinical Characteristics and Prognosis in 20 Juvenile Dermatomyositis[J].The Chinese Journal of Dermatovenereology,2019,(01):1153.[doi:10.13735/j.cjdv.1001-7089.201809121]
[4]熊梦燎,李卉,周文明.皮肌炎和系统性红斑狼疮重叠综合征伴Degos样皮疹1例[J].中国皮肤性病学杂志,2020,(08):915.[doi:10.13735/j.cjdv.1001-7089.201909066]
XIONG Mengliao,LI Hui,ZHOU Wenming.A Case of Degos-like Lesions in Systemic Lupus Erythematosus-Dermatomyositis Overlap Syndrome[J].The Chinese Journal of Dermatovenereology,2020,(01):915.[doi:10.13735/j.cjdv.1001-7089.201909066]
[5]薛燕,聂舒,胡芳,等.多中心网状组织细胞增生症1例[J].中国皮肤性病学杂志,2021,(01):66.[doi:10.13735/j.cjdv.1001-7089.202002005]
XUE Yan,NIE Shu,HU Fang,et al.A Case of Multicentric Reticulohistiocytosis
XUE Yan,NIE Shu,HU Fang,BI Xinling[J].The Chinese Journal of Dermatovenereology,2021,(01):66.[doi:10.13735/j.cjdv.1001-7089.202002005]
[6]侯明慧,刘升云.临床无肌病性皮肌炎与皮肌炎临床差异的探究[J].中国皮肤性病学杂志,2019,(08):895.[doi:10.13735/j.cjdv.1001-7089.201809170]
HOU Minghui,LIU Shengyun.The Clinical Differences Between Amyopathic Dermatomyositis and Typical Dermatomyositis[J].The Chinese Journal of Dermatovenereology,2019,(01):895.[doi:10.13735/j.cjdv.1001-7089.201809170]